- House committee directs FDA to speed up IND sign-off processThe House Appropriations Committee told the FDA to reform the way it signs off on new clinical trials, reflecting a broader effort to ensure the US keeps pace with China and other nations in develo…Endpoints · 1mo ago↗ source
- Innovent declares Phase 3 success for ADC that attracted huge Takeda dealInnovent Biologics' ADC candidate has passed a Phase 3 trial in advanced stomach cancer and is under priority review in China, but details of the success are still under wraps. The Phase 3 win wi…Endpoints · 1mo ago↗ source
- Fulcrum lays off majority of staff; Seres extends runway into 2027👥 Fulcrum Therapeutics reduced to a shell: The biotech is letting go 48 of its 57 full-time employees, according to an SEC filing. The step comes after Fulcrum said